Thema
Journal Article
67
Research Support, Non-U.S. Gov't
47
Angiotensin II
20
Review
19
Research Support, U.S. Gov't, Non-P.H.S.
15
11128-99-7
14
Receptors, Angiotensin
12
Comparative Study
10
EC 3.4.24.-
10
Research Support, N.I.H., Extramural
10
Oligopeptides
9
AT4 receptor
7
Matrix Metalloproteinases
7
615
6
Angiotensin III
6
EC 2.7.10.1
6
Enzyme Inhibitors
6
Preeclampsia
6
c-Met receptor
6
che
6
23025-68-5
5
67256-21-7
5
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
5
Alzheimer’s disease
5
Angiotensins
5
EC 3.4.24.17
5
Hepatocyte Growth Factor
5
Matrix Metalloproteinase 3
5
Proto-Oncogene Proteins c-met
5
angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-
5
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
4
Aminopeptidases
4
Angiotensin IV
4
Angiotensin Receptor Antagonists
4
DL48G20X8X
4
EC 3.4.11.-
4
EC 3.4.24.35
4
Matrix Metalloproteinase 9
4
Parkinson’s disease
4
Renin
4
Scopolamine
4
12687-51-3
3
3K9958V90M
3
4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid
3
AT
3
Aminopeptidase A
3
Angiotensin
3
Angiotensin receptors
3
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
3
Cardiovascular disease
3
mehr ...